SCHEMBL6701289

SCHEMBL6701289

CC(C(=O)Nc1ccccc1Cc1ccccc1C(=O)O)c1ccc(COCc2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.52
MAPT P10636 1/20 0.46
CRHBP P24387 1/20 0.46
RAB9A P51151 1/20 0.46
CRHR2 Q13324 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
LMNA P02545 2/20 0.43
KDM4E B2RXH2 2/20 0.43
TRPV1 Q8NER1 1/20 0.41
CFD P00746 1/20 0.41
TSHR P16473 1/20 0.40
SLC16A3 O15427 1/20 0.40
POLB P06746 1/20 0.39
KCNQ2 O43526 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ABCC1 P33527 1/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5352027 0.89 PTGER4 (0.56) PTGER4L3MBTL1RAB9ALMNA
SCHEMBL5346187 0.89 PTGER4 (0.60) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5358711 0.87 MAPT (0.63) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5350278 0.85 PTGER4 (0.64) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5365542 0.84 PTGER4 (0.60) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5351093 0.83 PTGER4 (0.54) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5353711 0.83 PTGER4 (0.54) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL6700849 0.83 PTGER4 (0.64) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5347447 0.83 PTGER4 (0.56) PTGER4L3MBTL1MAPTCRHBPRAB9A
SCHEMBL5357447 0.83 PTGER4 (0.53) PTGER4L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-01 US claimed
EP-1314719-A1 BENZOIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP claimed
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-01 US disclosed
EP-1314719-A1 BENZOIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient PTGER1, PTGER4, PTGES PTGER4 2/4885L3MBTL1 4112/4885MAPT 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.